AR098880A2 - Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusión - Google Patents
Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusiónInfo
- Publication number
- AR098880A2 AR098880A2 ARP140104816A ARP140104816A AR098880A2 AR 098880 A2 AR098880 A2 AR 098880A2 AR P140104816 A ARP140104816 A AR P140104816A AR P140104816 A ARP140104816 A AR P140104816A AR 098880 A2 AR098880 A2 AR 098880A2
- Authority
- AR
- Argentina
- Prior art keywords
- mmol
- concentration
- electrolyte
- protective solution
- contained
- Prior art date
Links
- 230000001681 protective effect Effects 0.000 title abstract 5
- 210000000056 organ Anatomy 0.000 title abstract 2
- 230000010412 perfusion Effects 0.000 title abstract 2
- 230000010410 reperfusion Effects 0.000 title abstract 2
- 239000003792 electrolyte Substances 0.000 abstract 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- KBOJOGQFRVVWBH-ZETCQYMHSA-N N-acetyl-L-histidine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CN=CN1 KBOJOGQFRVVWBH-ZETCQYMHSA-N 0.000 abstract 2
- 229940009098 aspartate Drugs 0.000 abstract 2
- 150000002500 ions Chemical class 0.000 abstract 2
- 150000004702 methyl esters Chemical class 0.000 abstract 2
- CFAMAWCPWJCAFR-UHFFFAOYSA-N n-hydroxy-3,4-dimethoxy-n-methylbenzamide Chemical compound COC1=CC=C(C(=O)N(C)O)C=C1OC CFAMAWCPWJCAFR-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical class O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000005138 cryopreservation Methods 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- -1 lysine cation Chemical class 0.000 abstract 1
- 150000002668 lysine derivatives Chemical class 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Abstract
Una solución protectora para prevenir daños isquémicos en los órganos, o en sistemas celulares aislados, o en componentes de tejido después de la perfusión, operación, trasplante, o crio-conservación y subsiguiente reperfusión, que comprende un electrolito seleccionado del grupo que consiste en iones alcalinos y iones alcalino-térreos, un buffer, un poliol y/o un sacárido, en donde dicha solución tiene una osmolaridad de 290 mosm/L a 350 mosm/L, como también un pH con un valor de 6,8 a 7,4 y comprende ácido 3,4 dimetoxi-N-metiIbenzohidroxámico y/o una sal del mismo, dicha composición además comprende N-acetilhistidina como un agente buffer en combinación con arginina, con un contenido aniónico de aspartato, en la cual el ácido 3,4-dimetoxi-N-metilbenzohidroxámico y/o una sal del mismo está comprendido en una cantidad de hasta 10 mmol/L, en la cual la N-acetilhistidina está comprendida en una concentración de 30 mmol/L a 265 mmol/L, en la cual el sodio está contenido deliberadamente como un electrolito a una concentración de 10 mmol/L a 80 mmol/L, en la cual el potasio está contenido deliberadamente como un electrolito a una concentración de 5 mmol/L a 25 mmol/L, en la cual el magnesio está contenido deliberadamente como un electrolito a una concentración de 3,5 mmol/L a 27 mmol/L, en la cual el calcio está contenido deliberadamente como un electrolito a una concentración de 0,005 mmol/L a 0,095 mmol/L, en donde el aspartato está contenido a una concentración de hasta 140 mmol/L, y en donde el a-cetoglutarato está contenido a una concentración de 1 mmol/L a 9 mmol/L. Reivindicación 2: Solución protectora de acuerdo con la reivindicación 1, caracterizada porque comprende una adición de un derivado del ácido 6-hidroxi-2,5,7,8-tetrametilcromán-2-carboxílico, preferentemente del metil éster respectivo. Reivindicación 3: Solución protectora de acuerdo con una cualquiera de las reivindicaciones precedentes, caracterizada porque tiene un contenido de catión de lisina y/o derivado de lisina, preferentemente dipéptidos que contienen lisina. Reivindicación 5: Solución protectora de acuerdo con una cualquiera de las reivindicaciones 2 a 4, caracterizada porque el derivado del ácido 6-hidroxi-2,5,7,8-tetrametiIcromán-2-carboxílico, preferentemente como el derivado de metil éster, está comprendido en una concentración de hasta aproximadamente 10 mmoI/L.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10222561A DE10222561B4 (de) | 2002-05-17 | 2002-05-17 | Protektive Lösung zur Verhinderung von Ischämieschäden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR098880A2 true AR098880A2 (es) | 2016-06-22 |
Family
ID=29265373
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101726A AR039819A1 (es) | 2002-05-17 | 2003-05-16 | Solucion protectora para evitar danos isquemicos en organos |
| ARP140104816A AR098880A2 (es) | 2002-05-17 | 2014-12-19 | Solución protectora para prevenir daños isquémicos en los órganos o en sistemas celulares aislados o en componentes de tejido después de la perfusión, operación, transplante o crio-conservación y subsiguiente reperfusión |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101726A AR039819A1 (es) | 2002-05-17 | 2003-05-16 | Solucion protectora para evitar danos isquemicos en organos |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7977383B2 (es) |
| EP (2) | EP1362511B1 (es) |
| JP (1) | JP4603246B2 (es) |
| KR (2) | KR101014990B1 (es) |
| CN (1) | CN100448440C (es) |
| AR (2) | AR039819A1 (es) |
| AT (2) | ATE446676T1 (es) |
| BR (1) | BRPI0301159B8 (es) |
| CA (1) | CA2429097C (es) |
| DE (4) | DE10222561B4 (es) |
| DK (1) | DK1859679T3 (es) |
| ES (2) | ES2362867T3 (es) |
| MX (1) | MXPA03004315A (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10222561B4 (de) | 2002-05-17 | 2009-12-10 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
| AU2005247319B2 (en) | 2004-04-28 | 2011-12-01 | Molecules For Health, Inc. | Methods for treating or preventing restenosis and other vascular proliferative disorders |
| WO2005115141A1 (ja) * | 2004-05-26 | 2005-12-08 | National University Corporation Kagawa University | 希少糖を利用した細胞・組織・臓器保存液及び該液を用いる保存方法 |
| DE102007026392A1 (de) * | 2007-06-06 | 2008-12-11 | Bayer Healthcare Ag | Lösungen für die Perfusion und Konservierung von Organen und Geweben |
| EP2030615A3 (en) * | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases |
| US8835104B2 (en) | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
| EP2611291B1 (en) * | 2010-09-01 | 2020-03-25 | Perfusion Fluid Technologies, Inc. | Perfusion composition |
| JP2014518547A (ja) | 2011-04-07 | 2014-07-31 | フェンウォール、インコーポレイテッド | 削減された残存血漿容積を有する血小板濃縮物を提供するための自動化方法とシステムおよびそのような血小板濃縮物のための貯蔵媒体 |
| BRPI1101935B1 (pt) * | 2011-04-15 | 2017-12-12 | Universidade Federal De Minas Gerais | Antioxidant composition for preservation of organs and fabrics |
| DE102012005177A1 (de) | 2012-03-16 | 2013-09-19 | Bitop Ag | Organlagerlösung |
| NL2010010C2 (en) * | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
| CN103238586B (zh) * | 2013-03-28 | 2014-03-26 | 辽宁亿灵科创生物医药科技有限公司 | 一种心肌脏器保存液制备方法 |
| EP2821081A1 (en) | 2013-07-05 | 2015-01-07 | ResuSciTec GmbH | Protective solution for preventing or reducing reperfusion injury of the brain and the whole body |
| AU2014369916A1 (en) | 2013-12-24 | 2016-06-16 | Durect Corporation | Uses of oxygenated cholesterol sulfates (OCS) |
| US10285962B2 (en) | 2016-05-01 | 2019-05-14 | The Regents Of The University Of California | Glutarate compounds for treating ischemia-reperfusion injuries |
| DE102016125414A1 (de) | 2016-12-22 | 2018-06-28 | Bitop Ag | Zusammensetzung enthaltend N-Acetyldiaminobuttersäure |
| WO2019183793A1 (zh) * | 2018-03-27 | 2019-10-03 | 华东理工大学 | N-羟基吡啶酮类化合物及其用途 |
| KR20200069995A (ko) | 2018-12-08 | 2020-06-17 | 이은지 | 접이식 빗자루 |
| US20220322656A1 (en) * | 2019-08-28 | 2022-10-13 | The Regents Of The University Of Michigan | Preservation of organs for transplant and non-transplant surgeries |
| CN115867133A (zh) * | 2020-06-29 | 2023-03-28 | 密歇根大学董事会 | 用于治疗和预防器官损伤的组蛋白乙酰化调节剂 |
| EP4248959A1 (en) * | 2022-03-22 | 2023-09-27 | Dr. Franz Köhler Chemie GmbH | Preparation for reduction of pathological iron overload |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH639270A5 (de) | 1978-12-14 | 1983-11-15 | Koehler Franz Dr Chemie Kg | Protektive loesung fuer herz und niere. |
| EP0054635B1 (de) * | 1980-12-23 | 1985-02-13 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung für Herz und Niere und Verfahren zu deren Herstellung |
| US4419365A (en) | 1981-12-21 | 1983-12-06 | Ciba-Geigy Corporation | Method of treating Alzheimer's disease |
| US4562006A (en) * | 1984-01-11 | 1985-12-31 | Warner-Lambert Company | Cycloheptadiene derivatives |
| US4607053A (en) * | 1984-05-17 | 1986-08-19 | E. R. Squibb & Sons, Inc. | Arylhydroxamates useful as antiallergy agents |
| US4604407A (en) * | 1985-04-04 | 1986-08-05 | E. R. Squibb & Sons, Inc. | Hydroxamates |
| US4927571A (en) * | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
| DK36389A (da) | 1988-02-05 | 1989-08-06 | Eastman Kodak Co | Praeparat og fremgangsmaade til at forebygge vaevskader ved reperfusion |
| JPH11514326A (ja) | 1990-03-30 | 1999-12-07 | バイオメディカル フロンティアーズ インコーポレイテッド | 液体蘇生用医薬物 |
| WO1991015215A1 (en) | 1990-03-30 | 1991-10-17 | Biomedical Frontiers, Inc. | Fluid resuscitation |
| JP2768799B2 (ja) | 1990-04-12 | 1998-06-25 | 株式会社大塚製薬工場 | 心筋保護液 |
| CA2068333A1 (en) * | 1990-09-10 | 1992-03-11 | Austin L. Shug | Composition and method for protecting the heart during reperfusion |
| JP2860301B2 (ja) * | 1990-09-19 | 1999-02-24 | ヘキスト・マリオン・ルセル株式会社 | 臓器保存用溶液 |
| GB9024820D0 (en) * | 1990-11-15 | 1991-01-02 | Davies Michael J | Pharmaceutical compositions |
| US5498427A (en) * | 1990-11-20 | 1996-03-12 | Pasteur Merieux Serums Et Vaccines | Solutions for the perfusion, preservation and reperfusion of organs |
| US5290766A (en) * | 1991-02-18 | 1994-03-01 | The National Heart Foundation Of New Zealand | Cardioplegic compositions |
| US5405742A (en) * | 1993-07-16 | 1995-04-11 | Cyromedical Sciences, Inc. | Solutions for tissue preservation and bloodless surgery and methods using same |
| ATE218802T1 (de) * | 1993-08-12 | 2002-06-15 | Univ North Carolina | Spüllösung für organe und gewebe |
| US6321909B1 (en) * | 1997-02-13 | 2001-11-27 | Sky High, Llc | System for storing polyethylene glycol solutions |
| EP0938896A1 (en) * | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
| US6365338B1 (en) * | 1999-04-27 | 2002-04-02 | David A. Bull | Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source |
| DE10222561B4 (de) | 2002-05-17 | 2009-12-10 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
-
2002
- 2002-05-17 DE DE10222561A patent/DE10222561B4/de not_active Expired - Fee Related
- 2002-05-17 DE DE10262084A patent/DE10262084B4/de not_active Expired - Fee Related
-
2003
- 2003-05-14 DE DE50313573T patent/DE50313573D1/de not_active Expired - Lifetime
- 2003-05-14 ES ES03010783T patent/ES2362867T3/es not_active Expired - Lifetime
- 2003-05-14 DK DK07012466.4T patent/DK1859679T3/da active
- 2003-05-14 EP EP03010783A patent/EP1362511B1/de not_active Expired - Lifetime
- 2003-05-14 ES ES07012466T patent/ES2335145T3/es not_active Expired - Lifetime
- 2003-05-14 AT AT07012466T patent/ATE446676T1/de active
- 2003-05-14 AT AT03010783T patent/ATE503383T1/de active
- 2003-05-14 EP EP07012466A patent/EP1859679B1/de not_active Expired - Lifetime
- 2003-05-14 DE DE50312079T patent/DE50312079D1/de not_active Expired - Lifetime
- 2003-05-16 CA CA2429097A patent/CA2429097C/en not_active Expired - Lifetime
- 2003-05-16 KR KR1020030031134A patent/KR101014990B1/ko not_active Expired - Lifetime
- 2003-05-16 BR BRPI0301159A patent/BRPI0301159B8/pt not_active IP Right Cessation
- 2003-05-16 CN CNB031438474A patent/CN100448440C/zh not_active Expired - Lifetime
- 2003-05-16 MX MXPA03004315A patent/MXPA03004315A/es active IP Right Grant
- 2003-05-16 US US10/438,977 patent/US7977383B2/en not_active Expired - Lifetime
- 2003-05-16 AR ARP030101726A patent/AR039819A1/es not_active Application Discontinuation
- 2003-05-16 JP JP2003138927A patent/JP4603246B2/ja not_active Expired - Fee Related
-
2010
- 2010-08-11 KR KR1020100077083A patent/KR101061293B1/ko not_active Expired - Fee Related
-
2011
- 2011-06-02 US US13/152,056 patent/US9603354B2/en not_active Expired - Fee Related
-
2014
- 2014-12-19 AR ARP140104816A patent/AR098880A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1480132A (zh) | 2004-03-10 |
| DE10262084B4 (de) | 2009-12-24 |
| ATE446676T1 (de) | 2009-11-15 |
| ES2335145T3 (es) | 2010-03-22 |
| KR20030089495A (ko) | 2003-11-21 |
| KR101061293B1 (ko) | 2011-08-31 |
| BR0301159A (pt) | 2004-08-17 |
| DE50312079D1 (de) | 2009-12-10 |
| AR039819A1 (es) | 2005-03-02 |
| US9603354B2 (en) | 2017-03-28 |
| JP4603246B2 (ja) | 2010-12-22 |
| ATE503383T1 (de) | 2011-04-15 |
| US7977383B2 (en) | 2011-07-12 |
| BRPI0301159B1 (pt) | 2018-05-15 |
| JP2004002418A (ja) | 2004-01-08 |
| CN100448440C (zh) | 2009-01-07 |
| US20030215781A1 (en) | 2003-11-20 |
| EP1362511A1 (de) | 2003-11-19 |
| CA2429097A1 (en) | 2003-11-17 |
| KR20100093023A (ko) | 2010-08-24 |
| DK1859679T3 (da) | 2010-03-15 |
| EP1859679A1 (de) | 2007-11-28 |
| EP1362511B1 (de) | 2011-03-30 |
| DE10222561B4 (de) | 2009-12-10 |
| KR101014990B1 (ko) | 2011-02-16 |
| US20110300237A1 (en) | 2011-12-08 |
| ES2362867T3 (es) | 2011-07-14 |
| MXPA03004315A (es) | 2005-02-14 |
| DE50313573D1 (de) | 2011-05-12 |
| EP1859679B1 (de) | 2009-10-28 |
| BRPI0301159B8 (pt) | 2021-05-25 |
| DE10222561A1 (de) | 2003-12-04 |
| CA2429097C (en) | 2013-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101061293B1 (ko) | 허혈 예방을 위한 보호 용액 | |
| Aisen et al. | Ultramicroscopic and biochemical changes in ram spermatozoa cryopreserved with trehalose-based hypertonic extenders | |
| JP2014516981A5 (es) | ||
| CR8904A (es) | Formulaciones estabilizadoras | |
| AR072250A1 (es) | COMPOSICIONES DE INSULINA DE ACCION SUPERRAPIDA. BOMBA DE INSULINA, DISPENSADOR. SISTEMA DE LAZO CERRADO. METODO PARA PREPARAR COMPOSICIoN, USO. COMBINACION. KIT. | |
| AR093662A1 (es) | Agentes crioprotectores, composiciones crioprotectoras y criopreservadas, sus usos y metodos de criopreservacion | |
| Guan et al. | Cryopreservation of zebrafish (Danio rerio) oocytes using improved controlled slow cooling protocols | |
| Ahmed et al. | Supplementation of l-tryptophan (an aromatic amino acid) in tris citric acid extender enhances post-thaw progressive motility, plasmalemma, mitochondrial membrane potential, acrosome, and DNA integrities, and in vivo fertility rate of buffalo (Bubalus bubalis) bull spermatozoa | |
| ZA202210899B (en) | Solutons for increasing the stability and shelf life of an organ and tissue preservation solution | |
| JP3694730B2 (ja) | 組織の冷却保存液 | |
| BR112015015092A2 (pt) | processos para preservar a função de tecido ou órgão e para preparar formulação para preservar a mesma e kit respectivo | |
| Tomalty et al. | Kidney preservation at subzero temperatures using a novel storage solution and insect ice-binding proteins | |
| KR20210127774A (ko) | 소 생식세포의 동결 보존용 조성물 및 동결 보존 방법 | |
| WO2007014380A3 (en) | Composition and method for the restoration and preservation of transplant organs procured from dcd donors | |
| KR101546487B1 (ko) | 저밀도 지질단백질과 항산화제를 포함하는 정자 동결보존용 조성물 및 이의 용도 | |
| AR118158A1 (es) | Un método y composición para repeler insectos usando un agente repelente | |
| PE20081321A1 (es) | Composicion microbicida acuosa estabilizada contra la degradacion por luz ultravioleta en frutas o vegetales comestibles | |
| PE20030729A1 (es) | Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas | |
| Buranaamnuay et al. | The in vitro quality of frozen-thawed Asian elephant (Elephas maximus) spermatozoa in semen supplemented with Equex STM paste and oxytocin during and after cryopreservation | |
| JP2007224004A (ja) | 超小型豚の人工授精用精液の希釈保存剤。 | |
| ECSP056172A (es) | Composición agroquímica en suspensión acuosa | |
| MX2007000082A (es) | Compuesto de clatrato, metodo para controlar concentracion de solucion de ingrediente activo quimico agricola, acuosa y formulacion quimica agricola. | |
| RU2010146519A (ru) | Композиция биологически активных препаратов для повышения выживаемости осетровых рыб при искусственном воспроизводстве | |
| KR20230165334A (ko) | 줄기세포용 냉장 보존액 및 보존 방법 | |
| RU2140153C1 (ru) | Раствор для консервации донорской почки |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |